Rising High: Exclusive talk with psychedelic biotech company Awakn - InvestingChannel

Rising High: Exclusive talk with psychedelic biotech company Awakn

In this edition of “Rising High,” The Fly conducted an exclusive interview with Anthony Tennyson, chief executive officer of Awakn Life Sciences (AWKNF), a biotechnology company focused on developing and delivering psychedelic therapeutics to treat addiction. Here are some… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3471248/-Rising-High-Exclusive-talk-with-psychedelic-biotech-company-Awakn)

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire